| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.17 | 0.008 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.14 | 0.01 |